Today's focus

[BYD: New energy vehicles sold 331,800 units in May]

BYD announced that sales of new energy vehicles in May were 331,817 units, compared to 240,220 units in the same period last year. This year's cumulative sales volume was 1,271,325 vehicles, an increase of 26.80% over the previous year.

[Cyrus: Sales of new energy vehicles increased 298.62% year-on-year in May to 34,400 units]

Cyrus announced that sales of new energy vehicles in May were 34,400 units, up 298.62% year on year, with cumulative sales volume of 156,800 units this year, up 342.35% year on year.

[Qunxing Toys: The actual controller, Wang Sanshou, is cooperating with the Beijing public security authorities to assist in the investigation]

Qunxing Toys announced that Wang Sanshou, the company's actual controller, is cooperating with the Beijing public security authorities to assist in the investigation. Up to now, the company has not received written notifications from the public security authorities to assist in the investigation, nor is it aware of the specific matters involved in assisting in the investigation.

[Jingneng Thermal Power: Shareholders plan to reduce their total holdings of the company by no more than 4%]

Jingneng Thermal Power announced that Chen Xiuming, a shareholder holding 5.38% of the shares, plans to reduce the company's shares by no more than 7.9092 million shares through centralized bidding and bulk transactions (accounting for 3% of the company's total share capital). The company announced on the same day that Zhongshan GM Investment, a shareholder holding 2.6% of the shares, plans to reduce the company's shares by no more than 2,636,400 shares (1% of the company's total share capital) through legal methods such as centralized bidding transactions.

[SF Holdings: Issuance of overseas listed foreign shares (H shares) to be registered by the China Securities Regulatory Commission]

SF Holdings announced that the company recently received the “Notice of Filing Notice Concerning the Overseas Issuance and Listing of SF Holdings Co., Ltd.” from the China Securities Regulatory Commission. The company intends to issue no more than 625,497,800 overseas listed common shares and list them on the Hong Kong Stock Exchange.

Investments & Contracts

[Fuchun Co., Ltd.: Wholly-owned subsidiary signs “Technical Support Agreement” with Gravity]

Fuchun Co., Ltd. announced that Shanghai Junmeng, a wholly-owned subsidiary of the company, recently signed a “Technical Support Agreement” with Gravity Co.Ltd. (“Gravity”). The cooperation between the two parties is for Gravity and Shanghai Junmeng to cooperate on the distribution of “Ragnarok RO: The Birth of a New Generation” in authorized regions. Shanghai Junmeng is the exclusive technical supporter. Gravity pays the technical service fee to Shanghai Junmeng according to the agreed ratio based on game revenue. The authorized region is Japan.

Changes in equity

[Xinjinlu: Termination of the acquisition of shares in Anhui Tianbing Electronic Technology Co., Ltd.]

Xinjinlu announced that the 5th Interim Board of Directors Meeting of the Company in 2024 and the 4th Interim Supervisory Board Meeting in 2024 respectively reviewed and passed the “Proposal on Termination of the Acquisition of Shares in Anhui Tianbing Electronic Technology Co., Ltd.” In view of the major changes in the current objective situation, after friendly negotiations and careful decision-making, the company decided to terminate the above acquisition.

Increase/decrease holdings & repurchases

[Jin Chengxin: Shareholders plan to reduce their total holdings of the company by no more than 1.6183%]

Jin Chengxin announced that the three shareholders, Yingtan Jincheng, Yingtan Jinxin, and Mr. Yin Shizhou, plan to reduce their holdings of the company's shares through centralized bidding and bulk transactions within 3 months of 15 trading days from the date of disclosure. The total amount of reduced holdings will not exceed 9.9934 million shares, accounting for 1.6183% of Jin Chengxin's total share capital.

[Sanyangma: Shareholder Chongqing Wuxing Logistics plans to reduce its holdings by no more than 1%]

Sanyangma announced that shareholder Yuwuxing Logistics plans to reduce its shareholding by no more than 1%.

[Sanfang Alley: Chairman proposes to buy back the company's shares for 30 million yuan to 50 million yuan]

Sanfangxiang announced that Chairman Bian Huiliang proposed to buy back the company's shares for 30 million yuan to 50 million yuan, and that the repurchase of shares is intended to be used for equity incentives.

Operation & Performance

[BAIC Blue Valley: The subsidiary sold 5,433 vehicles in May]

BAIC Blue Valley announced that Beijing New Energy Vehicle Co., Ltd. sold 5,433 vehicles in May, compared to 4,085 vehicles in the same period last year; the total sales volume this year was 18,437 vehicles, a year-on-year decrease of 23.07%.

Financing & fixed growth

[Runze Technology: Intended to apply for registration and issuance of debt financing instruments not exceeding RMB 4 billion]

Runze Technology announced that the 21st meeting of the fourth board of directors of the company reviewed and passed the “Proposal on the Company's Intended Registration and Issuance of Non-financial Corporate Debt Financing Instruments in the Interbank Bond Market”. The board of directors agreed that the company applied to the China Interbank Market Dealers Association to register the issuance of non-financial corporate debt financing instruments in the interbank bond market of no more than RMB 4 billion (including 4 billion yuan). The types of debt financing instruments approved by the relevant regulatory authorities include ultra-short-term financing notes, medium-term notes, etc. (subject to actual approval by the China Interbank Market Dealers Association).

other

[Microchip Biotech: Announcement of the company's drug Sidabonamide tablets to be included as a breakthrough treatment]

Microchip Biotech announced that the company's product, sidabenamide tablets, was recently included in the publication list of breakthrough therapeutic varieties by the Drug Evaluation Center of the State Drug Administration. The publicity period is from May 31, 2024 to June 7, 2024. Sidabendamide has been approved for three indications in China: peripheral T-cell lymphoma, breast cancer, and diffuse large B-cell lymphoma.

[Jiu'an Medical: iHealth triple testing products and COVID-19 testing products obtained emergency use authorization and pre-marketing notice from the US FDA]

Jiu'an Medical announced that the following products of iHealth Labs Inc.'s US subsidiary have obtained approval from the US Food and Drug Administration (FDA): 1. The novel coronavirus, influenza A virus, and influenza B triple test (POC) kits have obtained emergency use authorization (EUA). 2. The novel coronavirus home testing (OTC) kit received the US FDA 510 (K) pre-marketing notice.

[Bailey Tianheng: Phase III clinical trial of BL-B01D1 completed the first patient enrollment]

Baili Tianheng announced that the phase III clinical trial for locally advanced or metastatic EGFR wild type non-small cell lung cancer that was previously treated with anti-PD-1/PD-L1 monoclonal antibodies and failed platinum-containing chemotherapy has recently completed the enrollment of the first test subjects.

[Shaanxi Energy: Linbei Coal, a holding subsidiary, has now resumed normal production in accordance with approval]

According to Shaanxi Energy's announcement, Linbei Coal, a holding subsidiary, received the “Response from the Linyou County Emergency Management Bureau on the Resumption of Work and Production by Shaanxi Linbei Coal Industry Development Co., Ltd.” (Linyi Emergency Response (2024) No. 37) on June 1, and agreed in principle to resume normal production at the coal mine belonging to Linbei Coal Industry. Linbei Coal has now resumed normal production in accordance with the approval.